The Journal of Clinical Investigation (Mar 2023)

Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations

  • Elise Marsan,
  • Dmitry Velmeshev,
  • Arren Ramsey,
  • Ravi K. Patel,
  • Jiasheng Zhang,
  • Mark Koontz,
  • Madeline G. Andrews,
  • Martina de Majo,
  • Cristina Mora,
  • Jessica Blumenfeld,
  • Alissa N. Li,
  • Salvatore Spina,
  • Lea T. Grinberg,
  • William W. Seeley,
  • Bruce L. Miller,
  • Erik M. Ullian,
  • Matthew F. Krummel,
  • Arnold R. Kriegstein,
  • Eric J. Huang

Journal volume & issue
Vol. 133, no. 6

Abstract

Read online

Mutations in the human progranulin (GRN) gene are a leading cause of frontotemporal lobar degeneration (FTLD). While previous studies implicate aberrant microglial activation as a disease-driving factor in neurodegeneration in the thalamocortical circuit in Grn–/– mice, the exact mechanism for neurodegeneration in FTLD-GRN remains unclear. By performing comparative single-cell transcriptomics in the thalamus and frontal cortex of Grn–/– mice and patients with FTLD-GRN, we have uncovered a highly conserved astroglial pathology characterized by upregulation of gap junction protein GJA1, water channel AQP4, and lipid-binding protein APOE, and downregulation of glutamate transporter SLC1A2 that promoted profound synaptic degeneration across the two species. This astroglial toxicity could be recapitulated in mouse astrocyte-neuron cocultures and by transplanting induced pluripotent stem cell–derived astrocytes to cortical organoids, where progranulin-deficient astrocytes promoted synaptic degeneration, neuronal stress, and TDP-43 proteinopathy. Together, these results reveal a previously unappreciated astroglial pathology as a potential key mechanism in neurodegeneration in FTLD-GRN.

Keywords